Literature DB >> 25939713

RBM28, a protein deficient in ANE syndrome, regulates hair follicle growth via miR-203 and p63.

Emily Warshauer1,2, Liat Samuelov1, Ofer Sarig1, Dan Vodo1, Albrecht Bindereif3, Moien Kanaan4, Uri Gat5, Dana Fuchs-Telem1, Noam Shomron6, Luba Farberov6, Metsada Pasmanik-Chor7, Gil Nardini8, Eyal Winkler8, Benjamin Meilik9, Isabelle Petit10,11, Daniel Aberdam10,11, Ralf Paus12, Eli Sprecher1,2, Janna Nousbeck1.   

Abstract

Alopecia-neurological defects-endocrinopathy (ANE) syndrome is a rare inherited hair disorder, which was shown to result from decreased expression of the RNA-binding motif protein 28 (RBM28). In this study, we attempted to delineate the role of RBM28 in hair biology. First, we sought to obtain evidence for the direct involvement of RBM28 in hair growth. When RBM28 was downregulated in human hair follicle (HF) organ cultures, we observed catagen induction and HF growth arrest, indicating that RBM28 is necessary for normal hair growth. We also aimed at identifying molecular targets of RBM28. Given that an RBM28 homologue was recently found to regulate miRNA biogenesis in C. elegans and given the known pivotal importance of miRNAs for proper hair follicle development, we studied global miRNA expression profile in cells knocked down for RBM28. This analysis revealed that RBM28 controls the expression of miR-203. miR-203 was found to regulate in turn TP63, encoding the transcription factor p63, which is critical for hair morphogenesis. In conclusion, RBM28 contributes to HF growth regulation through modulation of miR-203 and p63 activity.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  RBM28; alopecia; hair follicle; miR-203; p63

Mesh:

Substances:

Year:  2015        PMID: 25939713     DOI: 10.1111/exd.12737

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  8 in total

1.  MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.

Authors:  Zhao Xiaohong; Fan Lichun; Xie Na; Zou Kejian; Xiao Xiaolan; Wang Shaosheng
Journal:  Tumour Biol       Date:  2016-09-21

2.  Chi-miR-370-3p regulates hair follicle morphogenesis of Inner Mongolian cashmere goats.

Authors:  Erhan Hai; Wenjing Han; Zhihong Wu; Rong Ma; Fangzheng Shang; Min Wang; Lili Liang; Youjun Rong; Jianfeng Pan; Zhiying Wang; Ruijun Wang; Rui Su; Yanhong Zhao; Zhihong Liu; Zhixin Wang; Jinquan Li; Yanjun Zhang
Journal:  G3 (Bethesda)       Date:  2021-05-07       Impact factor: 3.154

3.  Biallelic splicing variants in the nucleolar 60S assembly factor RBM28 cause the ribosomopathy ANE syndrome.

Authors:  Carson J Bryant; Cláudia F Lorea; Hiram Larangeira de Almeida; Letícia Weinert; Leonardo Vedolin; Filippo Pinto E Vairo; Susan J Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

4.  Faulty ribosome biogenesis underlies the ribosomopathy alopecia, neurological defects, endocrinopathy (ANE) syndrome.

Authors:  Jennifer L Gerton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

5.  The molecular basis for ANE syndrome revealed by the large ribosomal subunit processome interactome.

Authors:  Kathleen L McCann; Takamasa Teramoto; Jun Zhang; Traci M Tanaka Hall; Susan J Baserga
Journal:  Elife       Date:  2016-04-14       Impact factor: 8.140

6.  Mapping of leptin and its syntenic genes to chicken chromosome 1p.

Authors:  Eyal Seroussi; Frédérique Pitel; Sophie Leroux; Mireille Morisson; Susanne Bornelöv; Shoval Miyara; Sara Yosefi; Larry A Cogburn; David W Burt; Leif Anderson; Miriam Friedman-Einat
Journal:  BMC Genet       Date:  2017-08-09       Impact factor: 2.797

7.  MiR-92a-1-5p and miR-328-3p Are Up-Regulated in Skin of Female Pattern Hair Loss Patients.

Authors:  Mariya Aksenenko; Nadezhda Palkina; Anna Komina; Tatiana Ruksha
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

Review 8.  Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy.

Authors:  Dimitri Papukashvili; Nino Rcheulishvili; Cong Liu; Fengfei Xie; Deependra Tyagi; Yunjiao He; Peng George Wang
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.